Vir Biotechnology Inc (VIR)

SG&A Expense Growth

29.38%

Quarterly · Period ending:

VIR logo

VIR SG&A Expense Growth

Latest reported29.38%
VIR Quarterly SG&A Growth (QoQ) (0.00% → 29.38%)
High-resolution chart · PNG

VIR sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vir Biotechnology Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
29.38%
-1.1729%
6.23%
-0.2334%
-6.937%
-10.3255%
3.7174%
-14.938%
-16.5633%
-7.2064%
-0.4406%
-12.5019%
0.6008%
15.1305%
-10.2631%
3.8086%
15.0675%
-35.1991%
93.8856%
5.4082%
12.5211%
9.4046%
23.1188%
9.8926%
29.5438%
7.1223%
28.0694%
15.0918%
-6.4026%
7.6739%
7.5061%
7.2527%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.